Linking Global Resources: TRUKING Technology's Full-Chain Platform for Pharmaceutical Solutions
The 2024 China-Africa Cooperation Forum Summit, held from September 4 to 6 in Beijing, marked a significant diplomatic event, hosting the largest number of foreign leaders in recent years. Amidst this international gathering, a landmark agreement was signed between one of Algeria’s leading pharmaceutical companies and TRUKING Technology, one of China’s foremost pharmaceutical equipment manufacturers. This strategic partnership goes beyond the traditional scope of equipment procurement, encompassing joint efforts to establish local sales and service centers, indicating TRUKING’s deeper expansion into global markets. Overseas expansion is a key focus for TRUKING’s Co-President, Zhou Feiyue, who emphasized the company’s efforts in building a comprehensive platform that integrates pharmaceutical equipment, production processes, and API (Active Pharmaceutical Ingredients) solutions—an innovative model driving the company’s international growth.
TRUKING’s Leadership in Pharmaceutical Equipment
During the 2024 National Pharmaceutical Industry Information Conference, TRUKING Technology was one of the few equipment-focused enterprises to be recognized on China’s Top 100 Pharmaceutical Companies list. This acknowledgment reflects TRUKING’s unique position in the pharmaceutical industry, where the company provides essential technology and equipment to large pharmaceutical manufacturers. Over the years, TRUKING has expanded its product lines from a few key offerings to dozens, enabling the company to offer comprehensive solutions for both liquid and solid dosage forms. With a network that spans over 180 countries and regions and partnerships with more than 90% of China’s top pharmaceutical firms, TRUKING has solidified its presence in the global pharmaceutical industry.
Following its 2017 acquisition of Germany’s Romaco Group, TRUKING has significantly expanded its international market presence and established sales and service centers in numerous countries. TRUKING’s strong “linkage power” allows it to connect industry players across borders, creating a platform for deep collaboration between pharmaceutical companies worldwide.
Pharmaceutical Manufacturing Excellence
In June 2024, TRUKING hosted its annual Open House Day, welcoming over 100 pharmaceutical companies from various regions to its headquarters in Ningxiang, Hunan. During this event, international participants had the opportunity to explore cutting-edge technologies and engage in discussions on current trends in the biopharmaceutical sector. One of the highlights was a visit to Hunan Warrant Pharmaceutical Co., a key partner of TRUKING. Here, participants witnessed a fully automated ampoule production line, a significant technological advancement that has improved efficiency and reduced operational costs.
Warrant Pharmaceutical, known for its innovation in both chemical and biological drug production, has utilized TRUKING’s advanced equipment to enhance its manufacturing capabilities. With its fully automated solutions, including technologies for BFS (blow-fill-seal) and prefilled syringes, Warrant has been able to meet the highest international standards, positioning itself for global market expansion.
Recommended by LinkedIn
Global Partnerships and Future Growth
TRUKING’s efforts to expand its influence internationally are not limited to providing equipment. The company also seeks to enhance the global presence of its Chinese partners by promoting their pharmaceutical products and manufacturing processes on the world stage. This dual empowerment strategy benefits both TRUKING and its partners by helping them grow their market share and improve their technological capabilities.
Warrant Pharmaceutical’s success in securing international registrations for various APIs, including Montmorillonite and Fosfomycin Trometamol, highlights the effectiveness of this collaboration. TRUKING’s contribution to Warrant’s automation and production standards has provided the foundation for Warrant’s global success.
The Role of API in Global Markets
The global market for Active Pharmaceutical Ingredients (APIs) is projected to reach $359.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.9%. This growth is driven by increasing demand for biopharmaceuticals and treatments for chronic and complex diseases. While synthetic APIs dominate the market due to their lower production costs and simpler development processes, the market for biological APIs is expected to expand rapidly due to their effectiveness in treating complex diseases. With North America and Europe leading the market, Asia-Pacific regions like China and India are expected to experience the highest growth due to their cost advantages and favorable regulatory environments.
TRUKING’s expansion into the API market, coupled with its expertise in pharmaceutical equipment, positions the company as a key player in supporting global health initiatives. As more pharmaceutical companies seek innovative solutions to meet growing healthcare demands, TRUKING’s comprehensive platform offers a vital bridge between pharmaceutical manufacturing and international markets.
A Global Vision for Health
TRUKING is not just a supplier of pharmaceutical equipment; it is a global connector of resources and expertise. By linking pharmaceutical companies from different regions, TRUKING fosters collaboration and innovation, helping to address the world’s most pressing healthcare challenges. As the global demand for medical technologies continues to rise, particularly in underserved regions, TRUKING’s full-chain solutions provide the infrastructure needed to build modern pharmaceutical facilities and improve healthcare access.
The future of healthcare lies in collaboration, and TRUKING invites pharmaceutical companies worldwide to join in this effort. Together, we can enhance global healthcare, especially in regions where medical infrastructure is lacking, and contribute to a healthier future for all.
In December 2024, TRUKING Technology will host the China High-End Pharmaceutical Enterprises Forum at its headquarters in Changsha. The event will focus on monoclonal antibodies, insulin, and heparin sodium production technologies, as well as the growing demand for APIs.